Helena W Rodbard MD MACE FACP
Diabetes, Lipid Metabolism
Endocrine and Metabolic Associates
Join to View Full Profile
3200 Tower Oaks BlvdSte 250Rockville, MD 20852
Phone+1 301-770-7373
Fax+1 301-770-7272
Dr. Rodbard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
George Washington UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1982
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 1979 - 1981
Paulista School of MedicineClass of 1972
Certifications & Licensure
MD State Medical License 1979 - 2025
DC State Medical License 1982 - 2000
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2014
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Baltimore Area Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
- Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 2 citationsThe Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus.Francesco Giorgino, Tadej Battelino, Richard M Bergenstal, Thomas Forst, Jennifer B Green
Journal of Diabetes Science and Technology. 2025-03-01 - Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the task...Katharine Barnard-Kelly, Tadej Battelino, Frank C Brosius, Antonio Ceriello, Francesco Cosentino
Cardiovascular Diabetology. 2025-02-07 - Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus.Andrew I Spitzer, Helena W Rodbard, Sheikh Usman Iqbal, Masato Nakazawa, Mary DiGiorgi
The Journal of Arthroplasty. 2024-09-01
Press Mentions
Effect of Sotagliflozin as an Adjunct to Insulin Therapy on Blood Pressure and Arterial Stiffness in Adults with Type 1 Diabetes: A Post Hoc Pooled Analysis of inTandem1 and inTandem2February 20th, 2021
Treating Hypertension Reduces CV Risks in Diabetes CareAugust 8th, 2019- Europe Embraces, FDA Rejects Use of SGLT Inhibitors for Type 1 DiabetesJuly 23rd, 2019
- Join now to see all
Committees
- member, AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE MANAGEMENT OF DIABETES MELLITUS
Professional Memberships
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
